Joe Slavinsky

Joe Slavinsky has extensive experience in the biopharmaceutical industry. Joe is currently the Co-Founder and Chief Business Officer at Marley Medical, a virtual primary care clinic focused on people with common chronic diseases. Prior to this, they worked at Propeller Health as the SVP of Business Development, where they focused on partnerships with pharmaceutical, biotechnology, and med tech companies. Joe also has experience at Gilead Sciences, where they worked in Corporate Development and Commercial Strategy roles. Additionally, they worked at Monogram Biosciences in a Strategic Marketing role and served as a Consultant at Presidio Pharmaceuticals / Achaogen. Earlier in their career, Joe was a Vice President and Senior Equity Research Analyst at Thomas Weisel Partners, providing primary research coverage of the biopharmaceutical industry. Joe also worked as a Portfolio Finance Analyst at Citadel Investment Group.

Joe Slavinsky has a Bachelor of Arts (BA) degree in Biology from Vanderbilt University. Joe also holds a Master of Public Health (MPH) degree in Epidemiology from the Tulane University School of Public Health and Tropical Medicine. Furthermore, Joe Slavinsky has a PhD in Epidemiology from Tulane University. The exact start and end years for each of these educational experiences are not provided.